Price movement over the last 24 hours
Adaptive Biotechnologies Corp vs Lowe`s Companies Inc — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while Lowe`s Companies Inc trades at $212.66 (market cap $123.86B). The key difference: Lowe`s Companies Inc is far larger — about 37.2× Adaptive Biotechnologies Corp's market cap, and Lowe`s Companies Inc pays a 2.26% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | LOW | |
|---|---|---|
Market Cap | $3.33B | $123.86B |
Sector | Health | Consumer Cyclical |
52-Week High | $22.37 | $287.39 |
52-Week Low | $10.24 | $206.62 |
Enterprise Value | $3.19B | $165.61B |
Dividend Yield | — | 2.26% |
Trailing returns across standard periods
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →Lowe's is the second-largest home improvement retailer in the world, operating 1,969 stores and servicing around 230 dealer-owned stores throughout the United States and Canada. The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a low-double-digit share of the domestic home improvement market, based on U.S. Census data and management's estimates for market size.
Read more on LOW →